People · Operator
Named in public records as an officer, director or promoter · active 2008–2022 · Other Health Care, Other Technology, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Fractyl Laboratories Inc. | — | Other Health Care | Series C | $290.1M | $309.5M | 2017 |
| Revision Optics Inc | — | Other Technology | Series B | $121.7M | $973.8M | 2010 |
| WindMIL Therapeutics, Inc. | — | Biotechnology | Series B | $44.9M | $72.4M | 2018 |
| Otonomy, Inc. | — | Biotechnology | Series B | $44.8M | $961.1M | 2010 |
| Corthera Inc | — | Other | Series B | $21.0M | $249.2M | 2009 |
| Colorescience | — | Other | Series B | $15.3M | $253.5M | 2012 |
| Orqis Medical Corp | — | Other Health Care | Seed | $1.2M | $29.6M | 2008 |
Brian Dovey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brian Dovey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian H. Dovey | 2 | 7 |
| Hemant Taneja | 1 | 21 |
| Wende Hutton | 1 | 16 |
| Ajay Royan | 1 | 13 |
| Olav B. Bergheim | 1 | 13 |
| Amy Schulman | 1 | 11 |
| Brian Halak | 1 | 10 |
| Mark Leschly | 1 | 9 |
| Jeffrey Harris | 1 | 9 |
| Risa Stack | 1 | 9 |
| Peter Bisgaard | 1 | 9 |
| David Weber | 1 | 8 |
| Stanley Lapidus | 1 | 7 |
| Jay Lichter | 1 | 7 |
| Court Turner | 1 | 6 |
| Heather Preston | 1 | 6 |
| John McKearn | 1 | 6 |
| Douglas Downs | 1 | 6 |
| Dennis Podlesak | 1 | 6 |
| Diane Marcou | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.